HIV antibodies do control infection: new hope for vaccines and treatment

According to a single-patient study published in the October issue of Nature Communications, B-cells and neutralizing antibodies might control HIV levels better than scientists previously suspected. The authors of the study note that the finding could open a new avenue for both preventive and treatment vaccines for HIV. To view the full text of the study, please click here.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account